Condition: Stomatitis · Sponsor: AstraZeneca
This is a multicenter, open-label, single-arm study of prophylaxis for Dato-DXd-related stomatitis in eligible patients with metastatic or inoperable locally recurrent breast cancer or locally advanced or metastatic Epidermal Growth Factor Receptor-Mutated (EGFRm) non-small cell lung cancer.
This description comes directly from the study's public registry record.
AstraZeneca Clinical Study Information Center · 1-877-240-9479 · information.center@astrazeneca.com
Always discuss trial participation with your own doctor first.
| Research Site | Tucson, Arizona, United States | Withdrawn |
| Research Site | Hot Springs, Arkansas, United States | Recruiting |
| Research Site | Little Rock, Arkansas, United States | Recruiting |
| Research Site | Duarte, California, United States | Not Yet Recruiting |
| Research Site | Glendale, California, United States | Not Yet Recruiting |
| Research Site | Lakewood, California, United States | Not Yet Recruiting |
| Research Site | Long Beach, California, United States | Recruiting |
| Research Site | Torrance, California, United States | Not Yet Recruiting |
| Research Site | Washington D.C., District of Columbia, United States | Withdrawn |
| Research Site | Plantation, Florida, United States | Not Yet Recruiting |
| Research Site | Athens, Georgia, United States | Recruiting |
| Research Site | Boise, Idaho, United States | Withdrawn |
+ 27 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07357597